October 4, 2007

CME News
New Low Back Pain Guidelines Discourage Routine Imaging or Rest for Most Patients

New clinical guidelines for low back pain (LBP) discourage routine imaging in nonspecific LBP, set criteria for diagnostic imaging including MRI, recommend NSAIDs or acetaminophin as first-line drugs, urge the addition of nondrug therapy in difficult cases, and tell physicians to keep patients moving...


Rheumatology News
First Case Reported of Lupus Erythematosus Tumidus Induced by Sex Reassignment Surgery

Environmental triggers contribute to lupus pathogenesis, and the hormone regimens used in male-to-female sex reassignment can induce lupus-like symptoms...


BioPharm Business News
Celera Receives Clinical Milestone Payment Based on Merck's Advancement of Odanacatib, a Cathepsin K Inhibitor; Phase III Trial for Osteoporosis Initiated

Celera, an Applera Corp business, announced a clinical milestone payment of $2 million from Merck & Co, Inc, under the cathepsin K inhibitor collaboration agreement between the companies...


Rheumatology News
Media Miss Point of Acupuncture Back Pain Study

Superficial needling at nonacupuncture points is as good as true acupuncture for relieving chronic low back pain and both are better than conventional therapy, raising the possibility that a “superplacebo effect” accounts for the benefits associated with acupuncture in previous studies...



Rheumatology and Infusion Therapy:
Practice and Treatment Choices in the New Era


The Scientific Basis of Individualized Treatment of Patients With RA: Online Byte-Size CME

To remove your e-mail address from our mailing list, please send a blank email to unsubscribe@fbhc.org. For questions and comments regarding this newsletter please contact info@ciaomed.org